Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Merck
Express Scripts
Chubb
Mallinckrodt
McKinsey
Johnson and Johnson
Argus Health

Generated: September 23, 2018

DrugPatentWatch Database Preview

Apopharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for APOPHARMA INC, and what generic alternatives to APOPHARMA INC drugs are available?

APOPHARMA INC has two approved drugs.

There are two US patents protecting APOPHARMA INC drugs.

Summary for Apopharma Inc
US Patents:2
Tradenames:1
Ingredients:1
NDAs:2

Drugs and US Patents for Apopharma Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes 8,703,156 ➤ Sign Up Y ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone TABLET;ORAL 021825-001 Oct 14, 2011 RX Yes Yes 7,049,328 ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone TABLET;ORAL 021825-001 Oct 14, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-002 Apr 20, 2018 RX Yes No ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes 7,049,328 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for APOPHARMA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 500 mg ➤ Subscribe 2016-01-29
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
UBS
Dow
Mallinckrodt
Federal Trade Commission
Cerilliant
US Department of Justice
Johnson and Johnson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.